Death domain-associated protein 6 (DAXX) was recently identified as a NOTCH target, whose levels were significantly increased in human breast cancers that were treated with endocrine therapy after a short treatment with a gamma secretase inhibitor [394]. Here, DAXX is linked to breast cancer.